NCT04950556

Brief Summary

The aim of our study is to investigate the effects of pelvic floor muscle training (PFMT) on pelvic floor muscle strength, sexual functions, bladder symptoms and quality of life in women with overactive bladder (OAB).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

July 6, 2021

Status Verified

June 1, 2021

Enrollment Period

1 year

First QC Date

June 27, 2021

Last Update Submit

June 27, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pelvic floor muscle strength

    The pelvic floor muscle strength of the patients will be evaluated by digital palpation. Change in pelvic floor muscle strength as measured with the Modified Oxford Scale, which ranges from 0 to 5

    change from baseline at 6 weeks

  • Sexual Function

    Female sexual function will be assessed using the Female Sexual Function Index. This 19-question questionnaire deals with the subject in a multidimensional way by questioning the states of desire, arousal, lubrication, orgasm, satisfaction and pain. The highest raw score that can be obtained from the questionnaire is 95, and the lowest raw score is 4.

    change from baseline at 6 weeks

Secondary Outcomes (3)

  • OAB symptoms

    change from baseline at 6 weeks

  • Urinary frequency, nocturia and the number of urinary incontinence

    change from baseline at 6 weeks

  • Life quality

    change from baseline at 6 weeks

Study Arms (2)

Exercise group

EXPERIMENTAL

Fast and slow contractions will be taught in PFMT. For fast contractions, they will be asked to contract and relax the pelvic floor muscles quickly. For slow contractions, they will be asked to contract the pelvic floor muscles slowly, keep them at maximum contraction and relax slowly. Ten slow contractions in addition to 10 fast contractions will be considered as 1 set of exercises. For the first week, they will be asked to do 5 sets of exercises per day, every day. Then, the number of sets will be increased by 5 each week and the number of sets will reach 30 in the 6th week. PFMT will be applied by the patients as a home program every day of the week for 6 weeks.

Other: Exercise

Control group

OTHER

Waiting list will included in control group.

Other: Control

Interventions

Pelvic floor muscle exercise will be given to the exercise group

Exercise group
ControlOTHER

No intervention

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having a diagnosis of overactive bladder
  • Being volunteer

You may not qualify if:

  • have a neurological disorder
  • only those with stress urinary incontinence
  • presence of advanced pelvic organ prolapse (stage 3-4)
  • Having a mental problem that will prevent cooperation in evaluation and / or applications
  • Women with the presence of malignant condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Bladder, Overactive

Interventions

Exercise

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Seyda Toprak Celenay

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seyda Toprak Celenay

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into two groups (control and exercise) for treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

June 27, 2021

First Posted

July 6, 2021

Study Start

July 1, 2021

Primary Completion

July 1, 2022

Study Completion

August 1, 2022

Last Updated

July 6, 2021

Record last verified: 2021-06